Janux Therapeutics Share Price Today
(NASDAQ: JANX)

Name: Janux Therapeutics Share Price (NASDAQ: JANX) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Janux Therapeutics share price is $32.93 & ₹2,778.72 as on 3 May 2025, 2.30 'hrs' IST

$32.93

▲

0.88

(2.75%)

Market is closed - opens 7 PM, 05 May 2025

View live Janux Therapeutics share price in Dollar and Rupees. Guide to invest in Janux Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Janux Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Janux Therapeutics share price movements

Today's Low: $32.87
Today's High: $33.70
$32.93
0.18%
Downside
Day's Volatility :2.46%
Upside
2.28%
52 Weeks Low: $22.52
52 Weeks High: $71.71
$32.93
31.61%
Downside
52 Weeks Volatility :68.6%
Upside
54.08%

Janux Therapeutics (JANX) Returns

Period	Janux Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-21.73%	-5.8%	0.0%
6 Months	-41.06%	-5.6%	0.0%
1 Year	-47.05%	-1.7%	0.0%
3 Years	213.02%	4.3%	-9.3%

Janux Therapeutics (JANX) Key Statistics

in dollars & INR

Previous Close	$32.05
Open	$33.0
Today's High	$33.7
Today's Low	$32.87
Market Capitalization	$1.9B
Today's Volume	$825.2K
52 Week High	$71.71
52 Week Low	$22.52
Revenue TTM	$10.6M
EBITDA	$-96.8M
Earnings Per Share (EPS)	$-1.28
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-10.09%

How to invest in Janux Therapeutics Stock (JANX) from India?

It is very easy for Indian residents to invest directly in Janux Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Janux Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Janux Therapeutics or JANX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Janux Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Janux Therapeutics shares which would translate to 0.026 fractional shares of Janux Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Janux Therapeutics, in just a few clicks!

Returns in Janux Therapeutics (JANX) for Indian investors in Rupees

The Janux Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Janux Therapeutics investment value today

Current value as on today

₹54,123

Returns

₹45,877

(-45.88%)

Returns from Janux Therapeutics Stock

₹47,049 (-47.05%)

Dollar Returns

₹1,172 (+1.17%)

Indian investors sentiment towards Janux Therapeutics (JANX)

-18%

Period: Apr 3, 2025 to May 3, 2025. Change in 30 Days versus previous period

Search interest for Janux Therapeutics Stock from India on INDmoney has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Janux Therapeutics

RA Capital Management, LLC
17.54%
FMR Inc
14.67%
HHG PLC
6.03%
Paradigm Biocapital Advisors LP
5.95%
Adage Capital Partners Gp LLC
5.18%
BlackRock Inc
4.61%

Analyst Recommendation on Janux Therapeutics

Rating

Trend

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Janux Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Janux Therapeutics Stock (JANX)

What analysts predicted

Upside of 159.14%

Target:

$85.33

Current:

$32.93

Insights on Janux Therapeutics Stock (Ticker Symbol: JANX)

Price Movement
In the last 3 years, JANX stock has moved up by 184.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 8.89M → 439.0K (in $), with an average decrease of 95.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -28.05M → -20.21M (in $), with an average increase of 38.8% per quarter
JANX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.2% return, outperforming this stock by 119.4%
Price to Sales
ForJANX every $1 of sales, investors are willing to pay $167.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Janux Therapeutics Technicals Summary

Sell

Neutral

Buy

Janux Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Janux Therapeutics (JANX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Janux Therapeutics Inc	27.78%	-41.06%	-47.05%	213.02%	18.5%
Regeneron Pharmaceuticals, Inc.	5.59%	-26.95%	-36.84%	-5.3%	5.42%
Beone Medicines Ltd	7.16%	23.32%	57.31%	60.26%	78.11%
Vertex Pharmaceuticals Incorporated	5.59%	6.0%	24.51%	88.14%	84.02%
Alnylam Pharmaceuticals, Inc.	9.96%	-3.97%	71.43%	89.58%	83.55%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Janux Therapeutics Inc	NA	NA	NA	-2.08	-0.1	-0.09	NA	17.32
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.91	39.38	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.1	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.38	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.44	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Janux Therapeutics Inc	Buy	$1.9B	18.5%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	5.42%	15.94	31.07%
Beone Medicines Ltd	NA	$28.2B	78.11%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$128.2B	84.02%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	83.55%	NA	-12.37%

Janux Therapeutics Dividend announcements

Janux Therapeutics Earnings
Janux Therapeutics’s price-to-earnings ratio stands at None

About Janux Therapeutics

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer. Its clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor that is in Phase 1 clinical trial for the treatment of various solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. Janux Therapeutics, Inc. has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. The company was incorporated in 2017 and is headquartered in San Diego, California.

Organization	Janux Therapeutics
Employees	81
CEO	Dr. David Alan Campbell Ph.D.
Industry	Services

Management People of Janux Therapeutics

Name	Title
Dr. David Alan Campbell Ph.D.	President, CEO & Director
Mr. Andy Hollman Meyer	Chief Business Officer

Important FAQs about investing in JANX Stock from India :

What is Janux Therapeutics share price today?

Janux Therapeutics share price today stands at $32.93, Open: $33.00 ; Previous Close: $32.05 ; High: $33.70 ; Low: $32.87 ; 52 Week High: $71.71 ; 52 Week Low: $22.52.

The stock opens at $33.00, after a previous close of $32.05. The stock reached a daily high of $33.70 and a low of $32.87, with a 52-week high of $71.71 and a 52-week low of $22.52.

Can Indians buy Janux Therapeutics shares?

Yes, Indians can invest in the Janux Therapeutics (JANX) from India.

With INDmoney, you can buy Janux Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Janux Therapeutics at zero transaction cost.

How can I buy Janux Therapeutics shares from India?

It is very easy to buy Janux Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Janux Therapeutics (JANX) be purchased?

Yes, you can buy fractional shares of Janux Therapeutics with INDmoney app.

What are the documents required to start investing in Janux Therapeutics stocks?

To start investing in Janux Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.